Table 1.
Patients' characteristics and EZH2 staining score.
| Patient ID | Gleason score | EZH2 staining score |
|---|---|---|
| 3 | 3+2 | - |
| 4 | 3+2 | - |
| 6 | 3+3 | +/- |
| 24 | 3+3 | - |
| 25 | 3+3 | - |
| 34 | 3+3 | - |
| 35 | 3+3 | - |
| 37 | 3+3 | - |
| 1 | 4+3 | +/- |
| 2 | 4+3 | +/- |
| 5 | 3+4 | + |
| 7 | 3+4 | - |
| 8 | 4+3 | + |
| 9 | 4+4 | + |
| 10 | 3+4 | - |
| 13 | 3+4 | + |
| 14 | 3+3 | - |
| 15 | 3+3 | - |
| 16 | 3+3 | +/- |
| 20 | 4+3 | - |
| 21 | 3+4 | + |
| 26 | 4+3 | + |
| 28 | 4+3 | + |
| 29 | 3+4 | - |
| 30 | 4+3 | + |
| 36 | 4+3 | +/- |
| 38 | 3+4 | + |
| 11 | 4+5 | +/- |
| 12 | 4+5 | ++ |
| 17 | 5+4 | +/- |
| 18 | 4+5 | +++ |
| 19 | 5+4 focal neuroendocrine prostate cancer | +++ |
| 22 | 4+4 | +++ |
| 23 | 5+4 | +++ |
| 27 | 4+4 | +/- |
| 31 | 5+4 | + |
| 32 | 5+4 | +++ |
| 33 | 4+5 | ++ |
The score index was assigned to distinguish intensity of EZH2 staining. - means no staining; +++ means maximum intensity.